Swedish Biotech Stock News

Scandic Hotels Group (OM:SHOT) has just combined full year 2025 earnings with a fresh dividend proposal. This gives you a clearer view of how recent trading performance aligns with the company’s plans for returning cash to shareholders. See our latest analysis for Scandic Hotels Group. The share price reaction has been subdued, with a 1-day share price return of a 3.16% decline and a year-to-date share price return of a 14.65% decline. However, the 3-year total shareholder return is around...

Executive appointment puts corporate development in focus Camurus (OM:CAMX) has drawn fresh attention after appointing Jane Buus Laursen as Chief Corporate Development Officer and executive management member. The move puts partnerships, licensing and M&A firmly on investors’ radar. See our latest analysis for Camurus. The executive hire comes at a time when momentum has cooled, with a 30 day share price return of 27.37% decline and a 1 year total shareholder return of 27.80% decline, even...

If you are wondering whether Saab's current share price still reflects good value, it helps to step back and look at what the market has been pricing into the stock. Over the past week Saab is roughly flat with a 0.1% return, has seen a 6.2% decline over the last month, yet sits on gains of 16.1% year to date and 83.1% over the past year, with a very large return over five years from a low base. These sharp longer term moves have kept Saab on many investors' watchlists, particularly as...

AB SKF (OM:SKF B) is in focus after announcing that its Automotive business will become a stand-alone company named SKF Vertevo, with a planned Nasdaq Stockholm listing targeted for Q4 2026, pending approvals. See our latest analysis for AB SKF. The latest share price of SEK251.2 comes after a 1 month share price return of 8%, while the 1 year total shareholder return of 11.76% and 3 year total shareholder return of 29.46% suggest gradually building momentum around the broader SKF story as...

What Implantica’s recent share performance tells you Implantica (OM:IMP A SDB) has been on the radar after a stretch of weaker share performance, with the stock down about 10% over the past month and 17% over the past 3 months. See our latest analysis for Implantica. That shorter term weakness, including a 3.8% 1 day share price decline to SEK44.25, sits alongside a 1 year total shareholder return of 29.2% and a 3 year total shareholder return of 42.3%. This suggests that recent momentum has...

Castellum (OM:CAST) has come under closer scrutiny after reporting a quarterly net loss along with a year over year revenue dip, while the Board also proposed no cash dividend for the 2025 financial year. See our latest analysis for Castellum. Despite the quarterly loss and the proposed halt to cash dividends, Castellum’s recent share price momentum has been positive, with a 1 month share price return of 9.13% and a 1 year total shareholder return of 4.30%. However, the 5 year total...

Earlier in 2026, BioGaia announced it had renewed and broadened its distribution agreement with regional partner Ewopharma, expanding access to its probiotic portfolio across more than 15 European countries. This enlarged footprint with a long-standing regional distributor could be important for BioGaia’s efforts to scale its international presence through partnership-led growth. We’ll now explore how the expanded Ewopharma distribution agreement may influence BioGaia’s investment narrative...

Bure Equity AB (publ) has reported fourth-quarter 2025 results showing revenue of SEK 552 million in the loss column and a net loss of SEK 577 million, while for the full year revenue turned to a SEK 4.60 billion loss alongside a SEK 4.68 billion net loss compared with the prior year’s profit. Despite this sharp swing from profit to loss and a loss per share of SEK 63.16 for 2025, the company has still affirmed an annual dividend of SEK 2.75 per share payable in May 2026, signaling a...

Wallenstam (OM:WALL B) has drawn fresh attention after recent trading, with the share last closing at SEK 45.66 and showing mixed return patterns over the past year and over longer periods. See our latest analysis for Wallenstam. For Wallenstam, the recent 12.57% 1 month share price return and 11.75% year to date share price return suggest momentum has picked up, even though the 1 year total shareholder return is slightly negative and the 5 year total shareholder return remains weak. If this...

Hexagon (OM:HEXA B) announced an integration between its Multivista construction documentation platform and Revizto, aimed at improving issue tracking and workflows on large projects. The company also appointed Renée Rädler as its first Chief People Officer, with responsibility for talent attraction, succession planning and HR governance. Hexagon, known for its digital reality and construction technology tools, is pushing further into connected workflows as project owners and contractors...

Ratos (OM:RATO B) shares are in focus after the company reported a fourth quarter net loss, higher full year 2025 net income, and an annual dividend to shareholders. See our latest analysis for Ratos. At a share price of SEK37.52, Ratos has posted a 1-day share price return of 1.96% and a 7-day share price return of 2.79%. The 1-year total shareholder return of 3.13% and 3-year total shareholder return of 27.13% point to momentum that has been built over a longer horizon, despite some softer...

In late February 2026, Ericsson and its partners announced a flurry of 6G, AI and 5G-Advanced milestones, including the world’s first pre-standard 6G over-the-air session in the US, live ISAC drone-detection trials in Texas, and new collaborations spanning private 5G, fintech, and AI-driven network testing. Together, these developments highlight how Ericsson is trying to extend its role beyond traditional network equipment into AI-native infrastructure, enterprise connectivity and financial...

If you are wondering whether Sinch shares offer good value at today's price, you are not alone. This article walks through what that price might really imply. The stock recently closed at SEK22.97, with returns of 3.2% over 7 days, a 14.1% decline over 30 days, a 25.1% decline year to date, a 3.1% decline over 1 year, a 37.6% decline over 3 years, and an 83.6% decline over 5 years. Recent headlines around Sinch have kept investors focused on the business model, balance sheet strength, and...

Epiroc (OM:EPI A) is back in focus after announcing plans to showcase autonomous, connected and electric mining equipment at Conexpo Con/Agg 2026, a move that ties directly into broader smart mining and emission-reduction themes. See our latest analysis for Epiroc. Against this backdrop, Epiroc’s 1 month share price return of 6.67% and 90 day share price return of 34.21% have added to a 1 year total shareholder return of 32.07%, suggesting that momentum has been building around its automation...

If you are wondering whether Skandinaviska Enskilda Banken is still fairly priced after its run in recent years, starting with a clear view of value can help you judge what the current share price really offers. The stock last closed at SEK192.80, with returns of 2.0% over 30 days, a 1.6% decline over 7 days, a 2.6% decline year to date and 20.0% over 1 year. This gives you a mix of recent hesitation and longer term strength to consider. Recent coverage around bank stocks has focused on...

Skanska (OM:SKA B) has secured a €28 million refurbishment contract in Helsinki, updating 1960s laboratory space for the HUS Diagnostic Center and adding a multi year healthcare project to its Nordic order book. See our latest analysis for Skanska. These new Nordic contracts arrive while Skanska’s share price sits at SEK278.0, with a 90 day share price return of 14.78% and a 1 year total shareholder return of 13.70%, suggesting momentum has been building over both shorter and longer...

BioGaia (OM:BIOG B) has renewed and widened its distribution agreement with Ewopharma, now covering more than 15 European countries. This move puts fresh attention on how its probiotics reach key markets. See our latest analysis for BioGaia. At a share price of SEK111.7, BioGaia has seen short term momentum pick up, with a 4.1% 1 day and 10.7% 90 day share price return, even though the 1 year total shareholder return shows a 4% decline and the 5 year total shareholder return of 57.7% points...

Germany’s 49% year-on-year jump in January heat pump subsidy applications, alongside a softer heating law that reduces renewable requirements, puts NIBE Industrier (OM:NIBE B) in a mixed position within a key market. See our latest analysis for NIBE Industrier. At a share price of SEK37.07, NIBE’s recent 7.57% 1 month share price return contrasts with a 7.25% decline in 1 year total shareholder return and a 65.32% drop over three years. This suggests momentum has picked up recently, while...

If you are wondering whether EQT is starting to look like value after a rough patch, this article will help you size up the stock using several common valuation checks. The share price closed at SEK 280.10 after recent returns of a 5.3% decline over 7 days, a 19.8% decline over 30 days and a 21.8% decline year to date, while the 3 year and 5 year returns stand at 21.2% and 23.5%. Recent coverage of EQT has focused on how the listed private equity model responds to changing market sentiment...

Castellum AB (publ) recently reported fourth-quarter 2025 results showing revenue of SEK 2,398 million and a net loss of SEK 114 million, alongside a basic loss per share of SEK 0.23 from continuing operations. At the same time, the Board proposed that no cash dividend be distributed for the financial year 2025, marking a clear shift in capital allocation priorities that may prompt investors to reassess expectations around income and balance sheet resilience. We’ll now examine how...

If you are wondering whether Swedbank is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about its value. Swedbank's share price, which last closed at SEK 347.8, has seen a 0.3% decline over the past week, a 0.3% gain over the past month, a 6.9% return year to date and a 47.1% return over the past year, with a 101.6% return over three years and a 212.3% return over five years. Recent coverage around Swedbank has...

Assessing recent performance in Svenska Handelsbanken (OM:SHB A) Svenska Handelsbanken (OM:SHB A) has drawn investor attention after recent share price moves, with the stock closing at SEK144.60 and showing positive returns over the past month, past 3 months, and year to date. See our latest analysis for Svenska Handelsbanken. While the latest share price of SEK144.60 follows a small 1-day share price decline, the 90-day share price return of 10.47% and 1-year total shareholder return of...

Saniona (OM:SANION) has wrapped up FY 2025 with a mixed top and bottom line, as Q4 revenue came in at 4.6m SEK and Basic EPS was a loss of 0.3 SEK, against a trailing twelve month EPS of 2.21 SEK on 434.4m SEK of revenue. Over the past few quarters, the company has seen revenue move from 313.4m SEK in Q4 2024 to 410.7m SEK in Q3 2025 before landing at 4.6m SEK in Q4 2025. Quarterly EPS has swung from 2.21 SEK on a trailing basis to 2.39 SEK in Q3 2025 and then to a Q4 loss, setting up an...

BioInvent International (OM:BINV) has wrapped up FY 2025 with fourth quarter revenue of 3.016 million SEK and a basic EPS loss of 1.91 SEK, while trailing twelve month figures show revenue of 226.495 million SEK and a basic EPS loss of 5.06 SEK. Over recent quarters, the company has seen revenue move from 21.369 million SEK in Q4 2024 to 22.06 million SEK in Q1 2025, 198.098 million SEK in Q2 2025, and 3.321 million SEK in Q3 2025, alongside quarterly basic EPS figures ranging from a 1.48 SEK...